Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-031498
Filing Date
2022-09-19
Accepted
2022-09-19 17:40:47
Documents
1
Period of Report
2022-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3476
  Complete submission text file 0000899243-22-031498.txt   4986
Mailing Address C/O ORCHARD THERAPEUTICS 101 SEAPORT BOULEVARD, 7TH FLOOR BOSTON MA 02210
Business Address
THOMAS FRANK E (Reporting) CIK: 0001242616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38266 | Film No.: 221251493

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Issuer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations